Literature DB >> 14555939

Primary non-Hodgkin's lymphoma of the bile ducts mimicking cholangiocarcinoma.

Kasturi Das1, Adrian Fisher, Dorian J Wilson, Andrew N dela Torre, Joseph Seguel, Baburao Koneru.   

Abstract

BACKGROUND: Primary non-Hodgkin's lymphoma (NHL) of the liver and bile duct mimicking cholangiocarcinoma is rare.
METHODS: The clinical and radiologic features and the treatment of 2 patients with primary NHL of the bile ducts are presented and analyzed together with cases collected from a review of the English literature between 1966 and 2003.
RESULTS: Fifteen patients with primary NHL, including our 2 patients, presented with clinical features mimicking cholangiocarcinoma. All had jaundice; 9 had systemic symptoms; 7 had abdominal pain; and 5 had mass lesions. All had biliary strictures as shown on cholangiography. Two patients were infected with human immunodeficiency virus-1. In only 1 patient was the diagnosis established without surgery. Immunophenotyping in 10 patients showed 9 B-cell tumors and 1 T-cell tumor. Twelve patients underwent resection. Seven received chemotherapy immediately after the diagnosis was made. Only 3 patients have survived more than 3 years, with the longest survival being 68 months.
CONCLUSIONS: Non-Hodgkin's lymphoma of the liver and bile duct must be considered in the differential diagnosis of patients with obstructive jaundice. If the correct diagnosis is made before surgery, current protocols of chemotherapy may be the primary modality of therapy. Surgical resection should be reserved to address complications of biliary obstruction or the failure of chemotherapy to eradicate localized disease.

Entities:  

Mesh:

Year:  2003        PMID: 14555939     DOI: 10.1067/s0039-6060(03)00149-1

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center.

Authors:  Bülent Odemiş; Erkan Parlak; Omer Başar; Osman Yüksel; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

2.  Outcomes in lymphoma patients with obstructive jaundice: a cancer center experience.

Authors:  William A Ross; Chukwuma I Egwim; Michael J Wallace; Michael Wang; David C Madoff; Jeffrey H Lee
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

3.  Primary non-Hodgkin lymphoma of the extra-hepatic bile duct: A case report.

Authors:  Nikolaos Pararas; Periklis G Foukas; Andreas Pikoulis; George Bagias; Dimitris Papakonstantinou; Vassiliki Pappa; Konstantinos Nastos; Emmanouil Pikoulis
Journal:  Mol Clin Oncol       Date:  2022-05-25

Review 4.  Unusual causes of extrahepatic biliary obstruction in children: a case series with review of literature.

Authors:  R Phani Krishna; Richa Lal; Sadiq S Sikora; S K Yachha; Lily Pal
Journal:  Pediatr Surg Int       Date:  2007-12-11       Impact factor: 1.827

5.  Primary extranodal non-Hodgkin's lymphoma of the common bile duct manifesting as obstructive jaundice: report of a case.

Authors:  Hideaki Dote; Koji Ohta; Rieko Nishimura; Norihiro Teramoto; Akinori Asagi; Seijin Nadano; Makoto Hamada; Isao Yoshida; Takaya Kobatake; Isao Nozaki; Yoshirou Kubo; Minoru Tanada; Akira Kurita; Shigemitsu Takashima
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

6.  Diffuse large B-cell lymphoma in the ampulla of vater causing obstructive jaundice: report of a case.

Authors:  Naru Kondo; Hiroshi Furuya; Shigeru Yamamoto; Akinobu Nakano; Yoshihiro Sakashita
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

Review 7.  Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management.

Authors:  Qianwen Wang; Kangze Wu; Xuzhao Zhang; Yang Liu; Zhouyi Sun; Shumei Wei; Bo Zhang
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

8.  Primary biliary lymphoma mimicking cholangiocarcinoma: a characteristic feature of discrepant CT and direct cholangiography findings.

Authors:  Min A Yoon; Jeong Min Lee; Se Hyung Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi; Sun-Whe Kim; Ja-June Jang
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.